Tyra Biosciences (TYRA) Accumulated Expenses (2020 - 2026)

Quarterly Accumulated Expenses fell 78.37% to $2.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Mar 2026, down 78.37% year-over-year, with the annual reading at $5.5 million for FY2025, 14.23% down from the prior year.

Tyra Biosciences filings provide 7 years of Accumulated Expenses readings, the most recent being $2.0 million for Q1 2026.

  • Accumulated Expenses hit $2.0 million in Q1 2026 for Tyra Biosciences, down from $5.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $9.3 million in Q1 2025 and bottomed at $863000.0 in Q1 2023.
  • Average Accumulated Expenses over 5 years is $3.8 million, with a median of $3.8 million recorded in 2024.
  • The largest annual shift saw Accumulated Expenses soared 371.6% in 2023 before it plummeted 78.37% in 2026.
  • Tyra Biosciences' Accumulated Expenses stood at $1.0 million in 2022, then soared by 371.6% to $4.8 million in 2023, then soared by 33.07% to $6.5 million in 2024, then dropped by 14.23% to $5.5 million in 2025, then tumbled by 63.64% to $2.0 million in 2026.
  • Per Business Quant, the three most recent readings for TYRA's Accumulated Expenses are $2.0 million (Q1 2026), $5.5 million (Q4 2025), and $3.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Tyra Biosciences 2.03 Bn 2.03 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.01 Mn
Dec 31, 2025 5.53 Mn
Sep 30, 2025 3.10 Mn
Jun 30, 2025 7.86 Mn
Mar 31, 2025 9.30 Mn
Dec 31, 2024 6.45 Mn
Sep 30, 2024 3.79 Mn
Jun 30, 2024 5.45 Mn
Mar 31, 2024 3.89 Mn
Dec 31, 2023 4.85 Mn
Sep 30, 2023 4.75 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 863,000.00
Dec 31, 2022 1.03 Mn
Sep 30, 2022 1.10 Mn
Jun 30, 2022 1.22 Mn
Mar 31, 2022 2.08 Mn
Dec 31, 2021 1.26 Mn
Sep 30, 2021 634,000.00
Dec 31, 2020 774,000.00